← SynDRA
O-2050
SynDRA canonical compound SYN0087294 — structure-anchored drug synonym record
| Primary target(s) | CNR1 |
| Mechanism of action | Cannabinoid receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Cannabinoid receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- EHMT2
- GMNN
- HDAC6
- LMNA
- SAMHD1
- TDP1
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- ACM4
- ACM5
- CP1A2
- CP2D6
- HTT
- MAPT
- PDE4B
Cross-references
Synonyms
- RefChem:928029
- DTXCID801515595
- O-2050-D3,13C
- orb1704271
- SCHEMBL12023407
- CHEBI:92047
- HMS3268K11
- AKOS024456727
- NCGC00092285-01
- DA-66291
- MS-33382
- HY-133533
- CS-0121059
- T23099
- BRD-K02590140-001-01-2
- N-[6-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-3-yl]hex-4-ynyl]methanesulfonamide
Look up O-2050 in the interactive SynDRA portal →